A detailed history of Van Eck Associates Corp transactions in Axonics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 1,957 shares of AXNX stock, worth $138,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,957
Previous 2,363 17.18%
Holding current value
$138,907
Previous $159,000 13.21%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$67.3 - $69.67 $27,323 - $28,286
-406 Reduced 17.18%
1,957 $138,000
Q2 2024

Jul 31, 2024

BUY
$66.47 - $69.65 $5,051 - $5,293
76 Added 3.32%
2,363 $159,000
Q1 2024

Apr 30, 2024

BUY
$56.67 - $69.36 $5,383 - $6,589
95 Added 4.33%
2,287 $157,000
Q4 2023

Feb 05, 2024

SELL
$49.38 - $63.75 $18,418 - $23,778
-373 Reduced 14.54%
2,192 $136,000
Q3 2023

Nov 08, 2023

BUY
$48.64 - $62.51 $4,815 - $6,188
99 Added 4.01%
2,565 $144,000
Q2 2023

Aug 03, 2023

BUY
$47.99 - $60.21 $1,247 - $1,565
26 Added 1.07%
2,466 $124,000
Q1 2023

May 03, 2023

BUY
$52.6 - $67.34 $20,303 - $25,993
386 Added 18.79%
2,440 $133,000
Q4 2022

Feb 08, 2023

BUY
$59.56 - $76.6 $122,336 - $157,336
2,054 New
2,054 $128,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.